US Patent Issued to JIANGSU KANION PHARMACEUTICAL on May 12 for "Multi-receptor (GLP-1 receptor, GIP receptor, and Gcg receptor) agonist protein" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,080, issued on May 12, was assigned to JIANGSU KANION PHARMACEUTICAL Co. LTD. (Lianyungang, China). "Multi-receptor (GLP-1 receptor, GIP rec... Read More

US Patent Issued to The Trustees of the University of Pennsylvania on May 12 for "Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy" (Pennsylvania Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,081, issued on May 12, was assigned to The Trustees of the University of Pennsylvania (Philadelphia). "Tn-MUC1 chimeric antigen receptor (CA... Read More

US Patent Issued to University Health Network on May 12 for "T cell receptors and methods of use thereof" (Canadian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,082, issued on May 12, was assigned to University Health Network (Toronto). "T cell receptors and methods of use thereof" was invented by Na... Read More

US Patent Issued to The Regents of the University of California, City of Hope on May 12 for "Chimeric antigen receptors against human cytomegalovirus" (California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,083, issued on May 12, was assigned to The Regents of the University of California (Oakland, Calif.) and City of Hope (Duarte, Calif.). "Chi... Read More

US Patent Issued to XLIFESC on May 12 for "T cell receptor recognising KRAS mutation and encoding sequence thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,084, issued on May 12, was assigned to XLIFESC LTD. (Guangdong, China). "T cell receptor recognising KRAS mutation and encoding sequence the... Read More

US Patent Issued to The Trustees of the University of Pennsylvania on May 12 for "Compositions and methods of NKG2D chimeric antigen receptor T cells for controlling triple-negative breast cancer" (Pennsylvania Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,085, issued on May 12, was assigned to The Trustees of the University of Pennsylvania (Philadelphia). "Compositions and methods of NKG2D chi... Read More

US Patent Issued to Mayo Foundation for Medical Education and Research on May 12 for "Materials and methods for treating cancer" (Colorado, Minnesota, Florida Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,086, issued on May 12, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.). "Materials and methods for tre... Read More

US Patent Issued to Alpine Immune Sciences on May 12 for "CD155 variant immunomodulatory proteins and uses thereof" (Washington Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,087, issued on May 12, was assigned to Alpine Immune Sciences Inc. (Seattle). "CD155 variant immunomodulatory proteins and uses thereof" was... Read More

US Patent Issued to AUTOLUS on May 12 for "Chimeric receptor comprising a ligand binding domain and an endodomain comprising a cytokine receptor endodomain and an intracellular T cell signalling domain" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,088, issued on May 12, was assigned to AUTOLUS Ltd. (London). "Chimeric receptor comprising a ligand binding domain and an endodomain compri... Read More

US Patent Issued to Chugai Seiyaku on May 12 for "Antigen-binding molecule for promoting disappearance of antigen via FcGammaRIIB" (Japanese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,089, issued on May 12, was assigned to Chugai Seiyaku K.K. (Tokyo). "Antigen-binding molecule for promoting disappearance of antigen via FcG... Read More

• ««
• «
• 2138
• 2139
• 2140
• 2141
• 2142
• 2143
• 2144
• 2145
• 2146
• 2147
• »
• »»